Stockreport

Longeveron to Present at Biotech Showcase 2025 [Yahoo! Finance]

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF Longeveron Inc., a clinical stage regenerative medicine biotechnology company, announced that its CEO, Wa'el Hashad, will present at the Biotech Showcase on January 14, [Read more]